AlphAIAlphAI — Financial news for AI agents
scanx.tradeSEP 82 min read$BWXT

BWX Technologies stock delivers 22.77% annualized return over five years

BWX Technologies (NYSE: BWXT) has delivered a 22.77% annualized return over the past five years, outperforming the broader market by 11.2%. The company's stock is currently trading at $158.00, with a market capitalization of $14.48 billion. BWXT will host an Investor Day on September 29, 2026, featuring presentations by its executives.

Original reporting
scanx.trade
Published Sep 8, 2026, 6:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 7:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
BWX Technologies stock delivers 22.77% annualized return over five years — source image
Source · scanx.trade
Decision brief

The 30-second read

$BWXTNeutralLow
01

Why it matters

The Investor Day announcement provides a timeline for potential new information that could affect the stock.

02

Market read

While the historical performance is notable, the primary actionable element is the upcoming Investor Day, which may affect short-term trading.

03

What to watch

Potential macro risk from defense spending cuts or regulatory changes could dampen outlook.

Relevance 5/10Novelty 3/10Timing: upcoming Sep 29 2026

Background

BWX Technologies is a defense technology firm with a 5-year annualized return of 22.77% and plans an Investor Day.

Company-level read

Ticker impact

$BWXTNeutralMedium confidence
Context

Article announces BWX Technologies' Investor Day on Sep 29, 2026 and highlights its 5-year annualized return.

Expected impact

Modest upside if guidance is positive; limited downside risk.

Evidence & confidence

Investor day announcements are standard corporate communications; impact depends on disclosed guidance.

Market effects

Sector

Highlights strength of defense and nuclear tech sector, may boost peer sentiment.

Regional

US defense sector focus; limited broader regional effect.

Global

Modest, as BWX is a mid-cap with niche exposure.

Counterpoint

What could challenge this read

Past performance may not repeat; investors should wait for concrete guidance before acting.

Key entities

  • Executive
    Rex D. Geveden

    President and CEO of BWX Technologies

  • Executive
    Mike T. Fitzgerald

    Chief Financial Officer of BWX Technologies

Read at source← All news

Related articles

SEP 15
$BWXTMed

Jim Cramer Favors BWX Technologies (BWXT) Over Cameco (CCJ)

Jim Cramer prefers BWX Technologies (BWXT) over Cameco (CCJ) for nuclear power investment, citing BWXT's stronger recent performance and Cameco's longer-term potential. BWXT reported Q2 revenue of $901.6M, up 18% YoY, and raised 2026 guidance. Cameco's Q2 uranium segment revenue fell to C$252M from C$352M YoY, but maintained production outlook. Both companies saw increased hedge fund interest.

insidermonkey.com2 min
SEP 15
$BWXTHigh

BWXT Looks 4.3% Undervalued on GF Value™

Guggenheim initiated coverage on BWX Technologies (BWXT) with a Buy rating and $192 price target, citing its strategic nuclear sector position. GF Value™ indicates BWXT is 4.3% undervalued at $148.53 vs. $155.28 intrinsic value. The company has a GF Score™ of 93/100, strong growth, and profitability but faces insider selling and premium valuation concerns.

gurufocus.com2 min
SEP 14
$BWXTMed

Bwxt stock hits 52-week low at 146.1 USD

BWX Technologies Inc. (BWXT) stock hit a 52-week low of $145.91, down 40% from its high. Q2 2026 earnings beat estimates at $1.07 EPS, but revenue missed at $901.6M. Sales rose 18% YoY, and the company raised full-year free cash flow guidance to $345M-$360M. BWXT's backlog grew to $8.4B, up 40% YoY. Jefferies initiated coverage with a Buy rating, and Wells Fargo upgraded to Equal Weight.

uk.investing.com2 min
SEP 10
$BWXTMed

Can BWXT's Canadian Lab Role Strengthen Nuclear Services Growth?

BWX Technologies (BWXT) is expanding its nuclear services through a new Canadian lab management role via a joint venture. The contract began in December 2025, complementing BWXT's broader strategy. The Kinectrics acquisition, completed in May 2025, is key to this expansion. BWXT's commercial revenues grew 62.8% YoY to $853.1M in 2025, with Kinectrics contributing $231M. Analysts expect EPS growth of 18.45% and 10.73% for 2026 and 2027, respectively.

finance.yahoo.com2 min
SEP 7
$CCJMed

Jefferies Sees Cameco (CCJ) and BWXT as Winners in the Nuclear Boom

Jefferies initiated coverage of Cameco (CCJ) and BWXT (BWXT) with 'Buy' ratings, setting price targets of $138 and $181 respectively, citing strong long-term prospects in nuclear energy. CCJ, a major uranium producer, and BWXT, a nuclear reactor provider, are positioned to benefit from global and U.S. initiatives to expand nuclear capacity. Both companies face risks, including uranium price volatility for CCJ and execution challenges for BWXT.

finance.yahoo.com3 min
SEP 6
$BWXTHighAI 8/10

BWX Technologies Already Builds Reactors for the Navy. Why Is It Still the Cheapest Nuclear Stock?

BWX Technologies (NYSE: BWXT) is the lowest-valued nuclear stock despite its monopoly in supplying nuclear reactors and fuel to the U.S. Navy. Its Q2 revenue rose 18% YoY to $901.6M, with EPS up 5% to $1.07. The company has an $8.6B backlog and raised its yearly revenue guidance to $3.8B. BWX also expanded into commercial markets, with Q2 commercial revenue up 72% YoY to $303M.

currently.att.yahoo.com2 min